05.22.23 -- Maximizing Trial Success: Strategies, Considerations, And Partnership Retention

Strong relationships between a sponsor’s CRO and its clinical sites are instrumental to study success. Discover how effective site monitors drive open communication, information-sharing, and a mutual understanding of the other party’s challenges conducive to fruitful site relationships.

Rare disease protocol design, vendor selection, patient recruitment and retention, and site and patient qualification can be undermined by several factors. Learn why the clinical research community must use its influence to ensure trials are designed and executed in a way that considers each patient’s situation and overall well-being.

Biopharma organizations can inspire and motivate investigators and sites by showing them in both word and deed that their contributions are valued, resulting in a trickle-down effect: well-supported physicians and sites are better equipped to provide optimal patient care and to execute trials with greater efficiency, accuracy, and enthusiasm.
 

A comprehensive gap analysis examines documented procedures, SOPs, and QMS processes but also includes discussions with key personnel and scrutinizes outputs derived from these factors. Explore the “report card” — an independent key deliverable that helps the organization identify, prioritize, and remediate potentially problematic areas.